Signals, Powered By EquityPandit
Lupin has received the establishment investigation report (EIR) for the successful inspection of its Pithampur, Unit 1, from USFDA.
The inspection was carried out during July 2017. Nilesh Gupta, Managing Director of Lupin stated, “The successful outcome of this inspection is encouraging, and further validates our commitment to meeting global manufacturing standards. We are committed to upholding the highest levels of quality and compliance standards across all our facilities.”
